IL-17-high asthma with features of a psoriasis immunophenotype |
|
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children |
|
Anaphylaxis increases 8-iso-prostaglandin F2alpha release from guinea-pig lung in vitro |
|
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases |
|
Blood levels of vasoactive intestinal polypeptide in normal and growth retarded fetuses: relationship with acid-base and haemodynamic status. |
|
Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends. |
|
Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort |
|
The Combined Impact of Exhaled Nitric Oxide and Sputum Eosinophils Monitoring in Asthma Treatment: A Prospective Cohort Study. |
|
Diagnosing nonimmediate reactions to penicillins by in vivo tests. |
|
Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma |
|
Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma |
|
Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort |
|
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux |
|
Evidence for dual components in the non-adrenergic non-cholinergic relaxation in the rat gastric fundus: role of endogenous nitric oxide and vasoactive intestinal polypeptide. |
|
Exhaled breath condensate: methodological recommendations and unresolved questions. |
|
Exhaled nitric oxide as a biomarker in COPD and related comorbidities |
|
Exhaled nitric oxide measurement in patients affected by nasal polyposis. |
|
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis. |
|
High sputum total adiponectin is associated with low odds for asthma |
|
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma |
|
In vitro testing for lung toxicity: a method for distinguishing between immune- and non-immune-mediated reactions to xenobiotics |
|
Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma |
|
Inflammatory response to sputum induction measured by exhaled markers |
|
Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD. |
|
Interleukin-1β- and tumour-necrosis-factor-induced inhibition of rat gastric fundus motility in vitro |
|
Isoprostanes: markers and mediators of oxidative stress |
|
Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome |
|
Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers |
|
Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children |
|
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. |
|
New perspectives in monitoring lung inflammation analysis of exhaled breath condensate |
|
New perspectives in pharmacological treatment of mild persistent asthma |
|
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) |
|
Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide |
|
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping. |
|
Pharmacotherapy of asthma: regular treatment or on demand? |
|
Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues |
|
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients. |
|
Role of beta-blockers in patients with COPD: current perspective. |
|
Role of Leukotrienes and Leukotriene Modifiers in Asthma |
|
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis. |
|
Stratification of asthma phenotypes by airway proteomic signatures |
|
Tachykinin-eicosanoid crosstalk in airway inflammation. |
|
Tachykinin NK2 receptor antagonists decrease eicosanoid release in lung anaphylaxis |
|
Toward a personalized pharmacotherapy of respiratory diseases |
|
Treatable Traits in the European U-BIOPRED Adult Asthma Cohorts |
|
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics |
|
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type-2 Inflammation |
|
Validation of 8-isoprostane and prostaglandin E |
|
Validation of leukotriene B4 measurements in exhaled breath condensate |
|
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD |
|